Stock CANTA CANTARGIA AB
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cantargia AB

Equities

CANTA

SE0006371126

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:31 2024-05-24 EDT 		5-day change 1st Jan Change
3.54 SEK +7.21% Intraday chart for Cantargia AB -1.67% -5.30%
05-23 Cantargia Presents New Positive Clinical Data on Nadunolimab Counteracting Chemotherapy Induced Neuropathy CI
05-21 Transcript : Cantargia AB, Q1 2024 Earnings Call, May 21, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CANTARGIA AB Stock Cantargia AB
 61.07M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 23.4B -
ARGENX SE Stock argenx SE
 21.78B -
GENMAB A/S Stock Genmab A/S
 18.09B
  1. Stock Market
  2. Equities
  3. CANTA Stock
  4. Charts Cantargia AB
  5. Sector Chart